Fingerprint
Dive into the research topics of 'Ranibizumab in diabetic macular oedema - A benefit-risk analysis of ranibizumab 0.5 mg PRN versus laser treatment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ranibizumab in diabetic macular oedema - A benefit-risk analysis of ranibizumab 0.5 mg PRN versus laser treatment
Focke Ziemssen, Alan Cruess, Cornelia Dunger-Baldauf, Philippe Margaron, Howard Snow, William David Strain
Research output: Contribution to journal › Article › peer-review
4
Citations
(Scopus)